November is Epilepsy Awareness Month, a time to recognize the thousands of Long Islanders living with epilepsy and to recommit ourselves to creating a community prepared to protect them. More than ...

A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes for patients who continue to suffer seizures despite being on multiple ...

Epilepsy is one of the most common neurological disorders, affecting 3.4 million Americans or 1 in 26 over a lifetime. The hallmark of epilepsy is seizures caused by abnormal bursts of electrical ...

Seizure control may take time—often a year or more—but most patients achieve it, bringing new hope for life with epilepsy. For millions of people living with ...

Patients can spend anywhere from several days to several weeks in an epilepsy monitoring unit with electrodes protruding from holes drilled in their skulls. This is intracranial EEG, and it is now ...

A team of epilepsy specialists at UC San Francisco has developed a method to predict 24-hour seizure risk. The discovery, which may be scalable to large numbers of patients, could help to improve the ...

Researchers are optimistic after early results showed that experimental drug treatment zorevunersen may significantly reduce the number of seizures in children with a rare and severe form of epilepsy.

In temporal lobe epilepsy — a common and debilitating form of the disorder — seizures often cause those affected to lose consciousness. But why that happens has been unclear. In a new study, Yale ...

The American Academy of Neurology (AAN) has released its first guideline for the management of functional seizures, providing clinicians with timely recommendations on treating the commonly ...